G-protein activation revealed by [35S]-GTPγS binding assay is involved on the antidepressant-like effect of Hypericum caprifoliatum and Hypericum polyanthemum cyclohexane extracts  by Viana, Alice Fialho et al.
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Previous  studies  by  us demonstrated  the  antidepressant-like  and  antinociceptive  effects  of  lipophilic
extracts  and  dimeric  acyl-phloroglucinols  from  species  of  the  genus  Hypericum  native  to  Southern  Brazil.
Uliginosin  B and  HC1  (an enriched  phloroglucinol  fraction  from  Hypericum  caprifoliatum) are  able  to
inhibit  monoamine  synaptosomal  uptake  without  binding  to  the monoaminergic  sites  on  neuronal
transporters,  unlike  classical  antidepressants.  The  current  study  aimed  at investigating  the  action  of  H.
caprifoliatum  Cham.  & Schltdl.  and  Hypericum  polyanthemum  Klotzsch  ex  Reichardt,  Hypericaceae,  cyclo-
hexane  extracts  and  their  main  component,  HC1  and  uliginosin  B, on  G protein  coupled  receptors  by  using
the  [35S]-guanosine-5′-O-(3-thio)triphosphate  ([35S]-GTPS)  binding  assay,  which  reveals  the  G protein
activity.  The  antidepressant-like  effect  of acute  (one  or three  treatments  within  24 h) and  repeated  (ﬁve
days  with  and without  a three  day  wash-out)  treatments  with  the  cyclohexane  extracts  was  evaluated
using  the  rat  forced  swimming  test. The  [35S]-GTPS  binding  to monoamines  and opioid  receptors  stim-
ulated  by agonists  was  performed  ex vivo  in  brain  membranes  of  rats  acutely  or  repeatedly  treated  with
the cyclohexane  extracts.  The  effect  of  HC1 and  Uliginosin  B on [35S]-GTPS  binding  assay  was per-
formed  by direct  incubation  with  brain  membranes  in the  absence  of  agonists.  Their antidepressant-like
effect was evaluated  through  the  mice  forced  swimming  test.  The  extracts,  HC1  and  Uliginosin  B showed
antidepressant-like  effect  in  the forced  swimming  test.  The  acute  treatments  with  extracts  increased  the
[35S]-GTPS  binding  stimulated  by  the  monoamines,  while  after  ﬁve  days  of  treatment  the [35S]-GTPS
binding  was  reduced  even  after  three  day wash-out.  These  effects  are  not  due  to  HC1 or Uliginosin  B  inter-
action with  the  receptors,  since  direct  incubation  with  these  phloroglucinols  did  not  affect  [35S]-GTPS
binding  to membranes.  Our  ﬁndings  indicate  that  H. caprifoliatum  and  H. polyanthemum  extracts  bring
about  adaptive  changes  in monoamine  receptors,  which  reinforces  their  antidepressant-like  proﬁle.
©  2015 Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Natural products can be a source of substances with innovative
echanisms of action (Rates, 2001; Rollinger et al., 2006). In pre-
ious works we demonstrated that Hypericum caprifoliatum Cham.
 Schltdl. (HCP) and H. polyanthemum Klotzsch ex Reichardt (POL),
ypericaceae, cyclohexane extracts have potential antidepressant
nd antinociceptive effects (Viana et al., 2003, 2005; Stein et al.,
012; Stolz et al., 2012, 2014a,b). H. caprifoliatum extracts and
ts enriched phloroglucinol fraction (HC1) act on pre-synapse by
∗ Corresponding author.
E-mail: stela.rates@ufrgs.br (S.M.K. Rates).
http://dx.doi.org/10.1016/j.bjp.2015.06.008
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editorainhibiting monoamine uptake but differently from antidepressants
they do not bind to the monoamine sites on neuronal transporters
(Viana et al., 2005). Furthermore, the antidepressant like-effect in
the forced swimming test (FST) was  inhibited by dopamine D1
and D2 receptor antagonists (Viana et al., 2005). The antinocicep-
tive effect was blocked by naloxone (opioid receptor antagonist)
(Viana et al., 2003). POL and uliginosin B had similar effects, ulig-
inosin B was able to inhibit synaptosomal monoamine uptake
without binding to their sites on neuronal transporters (Stein et al.,
2012). The pretreatment with dopamine receptor antagonists, -
adrenoceptor antagonists, pCPA (inhibitor of serotonin synthesis)
and MK-801 (N-methyl-d-aspartic acid receptor antagonist) sig-
niﬁcantly prevented the HP4 antidepressant and antinociceptive
effects (Stein et al., 2012; Stolz et al., 2014a). Recently, Stolz et al.
 Ltda. All rights reserved.
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Fig. 1. Effect of T2 (three treatments during 24 h), T3 (two treatments per day during
ﬁve days) and T4 (two treatments per day during ﬁve days followed by a three
days wash-out) with 90 mg/kg of H. caprifoliatum (HCP), H. polyanthemum (POL) or
saline (SAL 1 ml/kg) on rat forced swimming test. Data are presented in mean ± SEM
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Fig. 2. Effect of acute treatment with the phloroglucinols HC1  (Hypericum caprifo-
liatum)  and HP4 (H. polyanthemum) 90 mg/kg p.o.; or saline (SAL 10 ml/kg) on mice
forced swimming test. Data are presented in mean ± SEM (n = 10 mice/group). Sig-
niﬁcantly different values were detected by one way  ANOVA followed by post hocn = 8 rats/group). Signiﬁcantly different values were detected by one way  ANOVA
ollowed by post hoc Student–Newman–Keuls test: *p < 0.05; **p  < 0.01; ***p < 0.001
s  compared to their respective saline (SAL) group.
2014b) veriﬁed that uliginosin B has synergistic effect with mor-
hine, while with amitriptyline or clonidine the interaction is
dditive. Altogether, these data indicate that the antidepressant
nd antinociceptive effects of the phloroglucinols from species
f Hypericum native to Southern Brazil involve the activation of
everal neurotransmission pathways, but direct evidence of their
bility to activate G protein coupled receptors (GPCR) are still
acking.
The knowledge that antidepressant agents affect GPCR func-
ion (Donati and Rasenick, 2003; Avissar and Schereiber, 2006;
zysz et al., 2015) prompted us to investigate the effect of
. caprifoliatum (HCP) and H. polyanthemum (POL) cyclohex-
ne extracts on some GPCR implicated with the mode of
ction of antidepressant and analgesic drugs by using the [35S]-
uanosine-5′-O-(3-thio)triphosphate ([35S]-GTPS) binding assay,
hich reveals the G protein activity. We  tested the effect of acute
nd repeated administration of HCP (H. caprifoliatum) and POL (H.
olyanthemum) cyclohexane extracts on immobility time in FST and
n monoamine and opioid receptor-stimulated [35S]-GTPS bind-
ng in rat brain membranes. We  have also investigated the effect the
hloroglucinols derivatives, HC1 and uliginosin B on mice FST and
arried out the [35S]-GTPS binding assay after direct incubation of
hese compounds with brain membranes.
aterials and methods
lant material and preparation of the extract
The aerial parts of Hypericum caprifoliatum Cham. and Schltdl.,
ypericaceae, were collected in the region of Viamão (29◦57′ S;
0◦59′ W),  and the ones from H. polyanthemum Klotzsch ex
eichardt, Hypericaceae, were collected in the region of Cac¸ apava
o Sul (30◦54′ S; 53◦87′ W).  The voucher specimens are deposited
n the herbarium of the Federal University of Rio Grande do Sul
ICN) (Bordignon, 1400 and 1429, respectively). Plant collection
as authorized by Conselho de Gestão do Patrimônio Genético
 CGEN and Instituto Brasileiro do Meio Ambiente – IBAMA –
03/2008 P 02000.001717/2008.60.
Hypericum extracts were prepared as described by Viana et al.
2005) and Stein et al. (2012). The phloroglucinol derivatives, HC1
rom H. caprifoliatum and uliginosin B (herein named HP4) from
. polyanthemum were isolated by means of thin layer and col-
mn  chromatography on preparative silica gel GF254 (Merck) usingStudent–Newman–Keuls test: ***p < 0.001 as compared to their respective saline
(SAL) group.
chloroform/hexane (3.5:1, v/v) as eluent (Nör et al., 2004; Stolz
et al., 2012).
Animals
Adult Male Sprague Dawley rats, weighing (180–200 g), were
purchased from IFFA-CREDO/Charles River Laboratories (Domaine
des Oncins, Saint-Germain sur L’Arbresle, France). Adult Male CF1
mice (25–35 g) from Fundac¸ ão Estadual de Produc¸ ão e Pesquisa em
Saúde (FEPPS-RS, Brazil) breeding colony were used. The rats were
housed by ﬁve in Makrolon cages (42 cm × 27.5 cm × 18 cm); mice
were housed in plastic cages (17 cm × 28 cm × 13 cm)  in groups of
eight mice. All animals were kept under a 12 h light/dark cycle
(lights on between 7 a.m. and 7 p.m.) in a well ventilated room,
at constant temperature of 22◦ ± 1 ◦C, with free access to standard
certiﬁed rodent diet and tap water. All the behavioral experi-
ments were performed according to guidelines of The National
Research Ethical Committee (published by National Heath Council
– MS,  1998), which are in compliance with the European Commu-
nities Council Directive of 24 November 1986 (86/609/EEC). The
behavioral experiments were approved by National Commission
of Research Ethics – Brazil (project approval number 01-188 at
07/26/2001).
[35S]-GTPS binding assay
Rats were submitted to four different treatment regimens with
POL or HCP 90 mg/kg, p.o.: T1 – one treatment by oral gavage 1 h
before the assays; T2 – three treatments within 24 h (23, 5 and
1 h before the sacriﬁce); T3 – two treatments per day during ﬁve
days; T4 – two treatments per day during ﬁve days followed by a
three day wash-out before the assays. The extracts were dissolved
in water with 5% polissorbate 80 to a concentration of 90 mg/ml,
the volume of administration was  1 ml/kg.
One hour after the last administration (T1, T2 and T3) or three
days later (T4) the animals were killed by decapitation. Frontal
cortex, striata, hypothalamus and thalamus were removed and
homogenized in 20 vol of 0.32 M sucrose. The same brain structures
were removed from non-treated rats to be used as control and for
direct incubation with HC1 or HP4 (10−10–10−6 M).  Crude mem-
brane preparations were isolated according to the modiﬁed method
described elsewhere (Viana et al., 2005). Brieﬂy, the homogenates
were centrifuged (1000 × g for 15 min); the supernatants from
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Fig. 3. Effect of T1 (single administration) with HCP, POL (90 mg/kg, p.o.) or saline on agonist-stimulated [35S]-GTPS binding measured ex vivo. Membranes prepared from
rat  striatum (A), hypothalamus (B), frontal cortex (C) and thalamus (D) were incubated with increasing doses of dopamine (A), noradrenaline (B), serotonin (C) or DAMGO (D)
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rom  four separated experiments carried out in duplicate.
wo centrifugations were combined and centrifuged (17,000 × g
or 30 min). The resulting pellet was then suspended in Tris buffer
50 mM Tris/HCl, 100 mM NaCl, 5 mM MgCl2, and 1 mM EDTA, pH
.4), sonicated, and centrifuged (50,000 × g for 10 min). The ﬁnal
rotein concentration was measured by the method of Lowry et al.
1951).
[35S]-GTPS binding assays were performed as follows. Mem-
ranes (15–20 g/100 l) were incubated in the assay buffer (Tris
uffer added with 1 mM dithiothreitol (DTT) and 0.1% metabisul-
hite) with 10 M GDP (Sigma–Aldrich Co.), 10−4–10−8 M of
opamine, noradrenaline, serotonin or DAMGO ([D-Ala2, N-Me-
he4, Gly5-ol]-Enkephalin) in the presence of 0.1 nM [35S]-GTPS
1250 Ci/mmol; Perkin-Elmer, Courtaboeuf, France) in a total vol-
me  of 1 ml.  Basal binding was assessed in the absence of
onoamines or DAMGO and presence of GDP (guanosine-5′-O-(3-
hio)diphosphate), and the non-speciﬁc binding was assessed in
he presence of 10 M GTPS (Sigma–Aldrich). In parallel, incuba-
ions with HC1 or HP4 in the absence of monoamines or DAMGO
ere made. The entire mixture was incubated at 25 ◦C for 2 h and
ltered through Whatman GF/B glass ﬁber ﬁlters, which had been
re-soaked for 2 h in Tris buffer, and washed three times with 4 ml
f ice-cold Tris buffer, using a Millipore Sampling Manifold (Biller-
ca, MA,  USA). Bound radioactivity was determined in Tri-Carb 2100
R liquid scintillation counter (Packard) after overnight extraction
f the ﬁlters in 4 ml  of Ultima Gold scintillation ﬂuid (Perkin-Elmer).
our independent experiments for each assay were carried out in
uplicate.f binding stimulation over GDP basal stimulation (absence of agonist). Mean ± SEM
Forced swimming test
Another batch of rats were submitted to treatments T2, T3 and
T4 and evaluated in the FST. In brief, before the beginning of the
treatment, rats were submitted to swimming for 15 min in 30 cm
deep water with temperature between 23 ± 2 ◦C. The ambient tem-
perature was approximately 22 ◦C. At the end of the swimming
exposition, the animals were removed from the water and gently
dried. One hour after the last treatment (T2 and T3) or three days
after treatment discontinuation (T4), the animals were submitted
to a second swimming exposure (5 min), and their immobility time
was measured. In order to evaluate the phloroglucinols derivatives,
HC1 and HP4, antidepressant-like effect, we  tested them at the sin-
gle dose of 90 mg/kg (p.o.) on mice FST according to Porsolt et al.
(1977, 1978) and Centurião et al. (2014).
Statistical analysis
The data were evaluated using one or two-way analysis of
variance (ANOVA) followed by Student–Newman–Keuls test or Stu-
dent’s t-test depending on the experimental design. p-Values less
than 0.05 were considered as statistically signiﬁcant.
The percent stimulation of [35S]-GTPS binding was calculated
according to the following formula: (S − B)/B × 100%, where S is the
stimulated level and B is the basal level of [35S]-GTPS  binding
in the presence of GDP. Individual concentration–response curves
were obtained by a non-linear regression analysis.
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Fig. 4. Effect of T2 (three treatments during 24 h (23, 5 and 1 h before assay) with HCP, POL (90 mg/kg, p.o.) or saline on agonist-stimulated [35S]-GTPS binding measured ex
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esults
orced swimming test
All treatment regimens with HCP [one-way ANOVA:
(5,53) = 17.46; p < 0.05] and POL [one-way ANOVA: F(5,54) = 4.89;
 < 0.05] signiﬁcantly reduced immobility time. The ﬁve day
reatments (twice a day) were not more effective than the classical
orsolt protocol (T2). The antiimmobility effect remained even
fter three days wash-out (T4) although less pronounced than
hose observed in T2 and T5 treatment twice a day (T3) (Fig. 1).
ven though there are no statistically signiﬁcant differences
etween POL and HCP treatments, it can be observed that the
OL effects are weaker than those of HCP (Fig. 1). Both HC1 and
P4 were effective in reducing mice immobility time [one-way
NOVA: F(2,27) = 12.36; p < 0.001] (Figs. 1 and 2).
35S]-GTPS binding assay
x vivo experiments
The different treatment regimens induced contrasting results.
reatments T1 and T2 with HCP and POL increased the maximal
ffect (Emax) of [35S]-GTPS binding induced by all monoamines
Figs. 3 and 4) and did not affect DAMGO curve features. The
onoamine potency (EC50) to induce [35S]-GTPS binding was also
ncreased.
Repeated treatment (T3 and T4) with HCP or POL induced a
eduction in the Emax and EC50 of [35S]-GTPS binding stimulated bythalamus (D) were incubated with increasing doses of dopamine (A), noradrenaline
ata are presented as percentage of binding stimulation over GDP basal stimulation
te.
monoamines (Figs. 5 and 6). This reduction was signiﬁcant for the
three monoamines when membranes were prepared one hour after
the last treatment (T3) and even following a three day wash-out
(T4). DAMGO-stimulated curves were not affected by the treat-
ments.
In vitro experiments
In order to verify whether the effects observed ex vivo were
related to direct phloroglucinols action on receptor functionality,
we evaluated the [35S]-GTPS binding stimulated by HC1 and HP4
in the absence of agonists. HC1 and HP4 were not able to stimulate
the binding of [35S]-GTPS to any of the G coupled to receptors in
membranes prepared from non-treated animals (data not shown)
(Fig. 7).
Discussion
Previous studies by us demonstrated the antidepressant-like
and antinociceptive effects of lipophilic extracts and dimeric
acyl-phloroglucinols from species of the genus Hypericum native
to Southern Brazil. The phloroglucinol derivatives, uliginosin
B (HP4) and HC1, inhibited monoamine synaptosomal uptake
in a concentration-dependent manner, without binding to
monoaminergic sites on neuronal transporters, unlike classical
antidepressants (Viana et al., 2005; Stein et al., 2012). The fact that
Hypericum phloroglucinol derivatives from Brazilian and European
species (Viana et al., 2005; Chatterjee et al., 1998; Müller et al.,
2001) inhibit monoamine uptake by a mechanism different from
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Fig. 5. Effect of T3 (two treatments per day during ﬁve days) with HCP, POL (90 mg/kg, p.o.) or saline on agonist-stimulated [35S]-GTPS binding measured ex vivo. Membranes
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C)  or DAMGO (D) in the presence of 0.1 nM [35S]-GTPS and 10 M GDP. Data are
gonist). Mean ± SEM from four separated experiments carried out in duplicate.
lassical antidepressants is coherent with their chemical structure;
hese molecules do not have nitrogen atom in their structure, which
s a core feature for binding to neuronal monoamines transporters
Appell et al., 2004). However, until this moment the molecular
echanisms by which extracts of Hypericum species exert their
ntidepressant-like effects remains unclear.
It is a consensus among the ﬁeld of psychopharmacology that
he increase of monoamine levels in the synaptic clef caused by
ptake inhibition is only the ﬁrst from a series of neurochemical
odiﬁcations induced by antidepressant. This increase evidently
ill lead to post synaptic modiﬁcations at different levels of the
ignaling cascades (Schreiber and Avissar, 2003; Millan, 2006;
tahl, 2008). Since antidepressant agents affect GPCRs function
Donati and Rasenick, 2003; Avissar and Schereiber, 2006; Czysz
t al., 2015) we decided to investigate the effect of H. caprifo-
iatum (HCP) and H. polyanthemum (POL) cyclohexane extracts
n monoaminergic receptors response in rat brain by measuring
gonist-induced [35S]-GTPS binding.
Acute and chronic treatments with the extracts showed oppo-
ite results regarding agonist-induced [35S]-GTPS binding: while
cute treatments (T1 and T2) increased it, repeated treatments (T3
nd T4) diminished it. The [35S]-GTPS binding increase indicates
rotein G activation and could be related to receptors response
o the sudden increase of monoamine at the synaptic cleft (Lohse
t al., 2008). The [35S]-GTPS binding reduction after 5 days of
reatment (T3 and T4) may  reveal a regulatory mechanisms result-
ng from the persistently high monoamines levels at the synaptic
left (Hermans, 2003; Stahl, 2008), which could also explain theere incubated with increasing doses of dopamine (A), noradrenaline (B), serotonin
nted as percentage of binding stimulation over GDP basal stimulation (absence of
persistent antiimmobility observed in the FST after 3 days of wash-
out. These results are in agreement with many experimental results
that show a reduction in [35S]-GTPS–G-protein coupling after
chronic treatment with several classes of antidepressant drugs
and monoamine transporter blockers (Hensler, 2002; O’Connor
et al., 2005; Castro et al., 2008; Rossi et al., 2008; Vidal et al.,
2010).
Receptors, transporters and G-proteins are not quiescent plasma
membrane proteins, many evidence support that they dynamically
trafﬁc to and from plasmatic membrane, both constitutively as well
as in response to psychostimulant exposure, receptor activation
and neuronal activity (Melikian, 2004; Chisari et al., 2007; Evans
et al., 2010). The GPCR decreased responsiveness after repeated
agonist treatment can occur through a variety of mechanisms,
including desensitization, down-regulation and redistribution of
cell surface receptors (trafﬁcking) (Ferguson, 2001; Harrison and
Traynor, 2003; Hermans, 2003; O’Connor et al., 2005). The exact
mechanisms that causes neuronal changes following antide-
pressant treatments are yet unknown. Many studies show that
antidepressants may  modulate the density of monoaminergic neu-
rotransmitter receptors in brains (Gould and Manji, 2002; Avissar
and Schereiber, 2006). It appears that GTP-binding properties of
G proteins are unaffected by antidepressant treatment, and their
effects on G-protein signaling do not include changes in receptor or
G protein gene expression (down regulation). Several studies have
demonstrated that the observed desensitization of monoaminer-
gic receptors following chronic antidepressant use is rather due
to a decrease in the efﬁcacy of coupling between receptor and
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Fig. 6. Effect of T4 (two treatments per day during ﬁve days followed by a three days wash-out) with HCP, POL (90 mg/kg, p.o.) or saline on agonist-stimulated [35S]-GTPS
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howed that antidepressants, like S-citalopram, but not the inac-
ive isomer R-citalopram, induce translocation of the subunit G
ut of lipid rafts.
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ments carried out in duplicate.
Regarding the in vivo tests, the FST is a good screening tool,
useful as a ﬁrst approach for assessing antidepressant activity
(Petit-Demouliere et al., 2005). At a ﬁrst glance, the activity of the
Hypericum extracts and their main phloroglucinols on FST seems
not to be directly related to the [35S]-GTPS results, since despite
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eing effective on FST, direct incubation of membranes with HC1
nd uliginosin B without agonists stimulation did not inﬂuence
35S]-GTPS binding. Therefore, the effects observed in the [35S]-
TPS binding after treating rats with POL and HCP could not be
redited to an agonist effect of uliginosin B or HC1 on monoamin-
rgic receptors. These results are in agreement with Ozawa and
asenick (1989) and Chen and Rasenick (1995) who observed that
ntidepressant drugs did not have direct effect on adenylyl cyclase,
 protein modulated by G subunit. In addition, antidepressants
hat acutely reduce immobility time in the FST, normally show
heir effects on GPCR only after 14–21 days of treatment (Hensler,
002; Pejchal et al., 2002; Shen et al., 2002; Castro et al., 2003).
hus, it is reasonable to consider that the effects of acute and the
 day treatments could be a consequence of monoamines increase
n the synaptic cleft following the uptake inhibition induced by the
xtracts, HC1 and uliginosin B (Viana et al., 2005; Stein et al., 2012).
Of note, the lack of inﬂuence over DAMGO-stimulated [35S]-
TPS binding curves supports the proposition that the extracts
ave a selective effect on monoaminergic system. This result
lso corroborates a previous hypothesis that the extracts present
ntinociceptive activity via indirect activation of opioid system,
ince this effect is prevented by naloxone, but their phloroglucinols
o not inhibit [3H]-naloxone binding (Stolz et al., 2012).
In conclusion, our ﬁndings indicate that, at doses for which
ntidepressant-like activity has been demonstrated in animal mod-
ls, H. caprifoliatum and H. polyanthemum extracts bring about
daptive changes in monoamine receptors, which reinforces their
ntidepressant-like proﬁle. These changes are not due to an ago-
ist action of HC1 or HP4 on monoaminergic receptors. They are
ikely to be a result of monoamines increase in the synaptic cleft,
n consequence of monoamines uptake inhibition. Further studies
re needed to elucidate which signaling pathways are activated
y these extracts and compounds, but the results so far conﬁrm
hat H. caprifoliatum and H. polyanthemum and their main dimeric
hloroglucinol derivatives constitute promising agents to ﬁnd out
ew antidepressants.
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